In this SPARK Europe Webinar, Lenka Součková & Radka Obermannová will present their experiences with the changes, that the New Clinical Trials Regulation has brought and which of them are related to the early-phase trails.
In this SPARK Europe Webinar, Dr. Peter Nestorov will talk about Scailytes’ experience and approach when selecting their initial and follow up indications based on various parameters.
In this SPARK Europe Webinar, Namir Hassan will speak about developing your idea into a growing business and the importance of an excellent and well-functioning team.
In this SPARK Europe Webinar Serie, Dr. Sabina Heim will shed light on those terms, touch upon the basic mechanisms of technology transfer in the life sciences and what to consider when you are working on a potential invention.
In this SPARK Europe Webinar Series, Dr. René Bernard, coordinator for Value and Open Science at the NeuroCure Excellence Cluster Berlin, will explain the hallmarks and latest developments of the EQIPD QS.
The SPARK-BIH office has moved to a new location. Come and have a look at the new building and offices at the CBI Open House Event on Wednesday, October 12th!
What is the utility of observational data? How does it differ from data collected under experimental conditions such as randomized controlled trials (RCTs)? Does it have any other value than optimizing market access in pharma companies?